evaluation of intravitreal autologous blood to remove posterior cortical vitreous in vitrectomy

evaluation of intravitreal autologous blood to remove posterior cortical vitreous in vitrectomy - intravitreal autologous blood to remove posterior cortical vitreous

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028187

Enrollment

Registered

2017-08-01

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epiretinal membrane, macular hole, retinal detachment, diabetic retinopathy, retinal vein occlusion, retinoschisis

Interventions

use of vitreous autologous blood

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Inpatient only 2 Patients undergoing vitrectomy 3 After receiving sufficient explanation for participation in this study, patients who obtained written agreement by the patient's free will with sufficient understanding.

Exclusion criteria

Exclusion criteria: 1 If the patient's consent was not obtained 2 Patients already have vitreous hemorrhage 3 Patients judged unsuitable as research subjects by research managers

Design outcomes

Primary

Measure	Time frame
Time to remove posterior cortical vitreous	—

Secondary

Measure	Time frame
Refraction, visual acuity, intraocular pressure, fundus examination, fundus photography, optical coherence tomography, axial length measurement	—

Countries

Japan

Contacts

Public ContactEIKO TSUIKI

Nagasaki University Hospital Ophthalmology

t-eiko@nagasaki-u.ac.jp095-819-7345

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026